IMMTF Stock UPDATES Immunotec Inc (IMMTF) 0.3340 09/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Immunotec Inc (IMMTF) 0.3340 $IMMTF

Immunotec to Appeal Recent Court Decision in Mexico
Marketwire - Mon Sep 15, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec" , announces its decision to appeal a recent unfavourable taxation court ruling in Mexico. The decision, received last week, denied certain favourable value-added tax ("VAT" refund requests based on an alleged misclassification of Immunocal products for VAT purposes in what the Company and many other market participants in Mexico believe is the absence of clear regulations.

Immunotec Files a Preliminary Short Form Prospectus
Marketwire - Thu Jul 03, 4:53PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a Canadian-based company and a leader in the wellness industry (the "Company" or "Immunotec" , is pleased to announce that it has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada in connection with a treasury offering of common shares ("Common Shares" in the capital of the Company (the "Primary Shares" and a secondary offering of Common Shares (the "Secondary Shares" and collectively with the Primary Shares, the "Offered Securities" by two selling shareholders of the Company (the "Selling Shareholders" for gross proceeds of $7 million to $15 million (the "Offering" .

Rowing Canada Aviron and Immunotec Inc. Announce Winning Clubs for Visit from National Team Members
Marketwire - Wed Jun 11, 3:29PM CDT
Rowing Canada Aviron and Immunotec Inc. are pleased to announce the winning rowing clubs for the Club and Coach Grant, Powered by Immunocal(R). The winning clubs will receive a visit from a National Team Coach and National Senior Team Athlete along with a $1,000 grant to be used to help the club maximise the opportunity of the visit.

Sigrid Beer Purchases 500,000 Common Shares of Immunotec Inc. from Robert M. Henry Living Trust
Marketwire - Fri Mar 28, 9:43AM CDT
Mrs. Sigrid Beer is pleased to announce that on March 25, 2014, she has purchased 500,000 common shares ("Common Shares" in the capital of Immunotec Inc. ("Immunotec" (TSX VENTURE: IMM) from Robert M. Henry Living Trust. These 500,000 Common Shares were purchased by way of a private agreement at a price of Cdn$175,000. Mrs. Beer has purchased such Common Shares as a result of a Settlement Agreement dated November 1, 2013 between Immunotec and Mr. Robert M. Henry. Mrs. Beer has no current intention of acquiring additional Common Shares.

Immunotec Announces 2014 First Quarter Results
Marketwire - Thu Mar 27, 11:24AM CDT
Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company" today released its first quarter results for the three-month period ended 31 January 2014.

Immunotec Announces Change in Marketing Management
Marketwire - Thu Mar 06, 4:18PM CST
Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company" today announced that Mr. Daniel Audet, Vice-President, Marketing, will be leaving Immunotec effective March 11, 2014 to pursue new opportunities.

Immunotec Announces Completion of its International Convention in Mexico City
Marketwire - Tue Feb 25, 3:06PM CST
Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company" today announces the completion of its International Convention held from February 20 to 22, 2014 at the Expo Bancomer Convention Center in Santa Fe, Mexico. Under the theme One Vision, One Team, nearly 1,500 independent Consultants participated in celebrating the Immunotec heritage of developing innovative products while being recognized for their accomplishments over the past year.

Immunotec Announces 2013 Fourth Quarter and Full Year Financial Results
Marketwire Canada - Thu Feb 13, 6:04PM CST
Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Company" today released its fourth quarter and full year results for the period ended 31 October 2013.

Immunotec Announces Third Quarter 2013 Financial Results
Marketwire - Thu Sep 12, 3:39PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company" or "Immunotec" , today released its third quarter 2013 financial results for the three- and nine-month periods ended 31 July 2013.

Immunotec Announces A Corporate Update
Marketwire - Mon Jul 15, 3:10PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Corporation" or "Immunotec" announced today that Mr. Robert Henry has tendered his resignation as a director of Immunotec.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading